Breast Cancer Clinical Trials in Massachusetts

Showing 281-300 of 602 trials

OPTimizing Treatment Focused Genetic Testing IN Cancer

NCT04066361

This two-part randomized controlled trial aims to evaluate the impact of pre-test video education as compared to pre-test Chatbot education.

Breast CancerOvarian CancerPancreatic Cancer+1 more

Dana-Farber Cancer Institute301 participantsStarted Dec 2019

Boston, Massachusetts, United States

TERMINATEDPhase 1/226 miles

A Study to Evaluate Rucaparib in Combination With Other Anticancer Agents in Participants With a Solid Tumor (SEASTAR)

NCT03992131

This is an open label, Phase 1b/2 study with multiple treatment arms evaluating the safety, tolerability, pharmacokinetics (PK), and preliminary efficacy of rucaparib in combination with a second anticancer therapy in participants with an advanced/metastatic solid malignancy (Phase 1b), followed by evaluation of the combination in one or more specific participant populations in an expansion phase (Phase 2 cohorts).

Ovarian CancerTriple-negative Breast CancerUrothelial Carcinoma+1 more

pharmaand GmbH25 participantsStarted Jun 2019

Boston, Massachusetts, United States • Nashville, Tennessee, United States • Houston, Texas, United States

TERMINATEDPhase 1/226 miles

Study of CB-103 in Adult Patients With Advanced or Metastatic Solid Tumours and Haematological Malignancies

NCT03422679

This is a phase I/II, non randomized, open-label, dose escalation study to investigate the safety, tolerability and preliminary efficacy of CB-103.

Breast CancerColorectal CancerAdenoid Cystic Carcinoma+5 more

Cellestia Biotech AG79 participantsStarted Dec 2017

Santa Monica, California, United States • Boston, Massachusetts, United States • Houston, Texas, United States +14 more locations

OPTimizing Treatment Focused Genetic Testing IN Cancer

A Study to Evaluate Rucaparib in Combination With Other Anticancer Agents in Participants With a Solid Tumor (SEASTAR)

Study of CB-103 in Adult Patients With Advanced or Metastatic Solid Tumours and Haematological Malignancies

Breast Cancer Trials in Other Cities

Losartan in Prevention of Radiation-Induced Heart Failure

A Breast Cancer Treatment Decision Aid for Women Aged 70 and Older

A Phase 1b Trial of ATRC-101 in Adults With Advanced Solid Malignancies

A Study of MGD013 in Patients With Unresectable or Metastatic Neoplasms

Breast Cancer Risk Assessment in Women Aged 40-49

Medroxyprogesterone +/- Cyclophosphamide & Methotrexate in Hormone Receptor-Negative Recurrent/Metastatic Breast Cancer

A Study of a New Drug Combination, Copanlisib and Fulvestrant, in Advanced Breast Cancer

Breast Cancer Registry for Participants With Breast Cancer or Characteristics of Hereditary Breast Cancer

Study to Assess the Safety and Efficacy of Ribociclib (LEE011) in Combination With Letrozole for the Treatment of Men and Pre/Postmenopausal Women With HR+ HER2- aBC

A Study to Investigate Atezolizumab and Chemotherapy Compared With Placebo and Chemotherapy in the Neoadjuvant Setting in Participants With Early Stage Triple Negative Breast Cancer

Development of a Questionnaire to Evaluate Patient Expectations for Breast Reconstruction in Women With Breast Cancer or Other Conditions

A Study of [225Ac]-FPI-1966 in Participants With Advanced Solid Tumours

A Study Evaluating the Safety, Pharmacokinetics and Efficacy of Ipatasertib Administered in Combination With Rucaparib in Participants With Advanced Breast, Ovarian Cancer, and Prostate Cancer.

SYD985 vs. Physician's Choice in Participants With HER2-positive Locally Advanced or Metastatic Breast Cancer

A Study Assessing the Safety and Effectiveness of IC2000 and SPY Fluorescence Imaging Systems (SPY-PHI) in the Visualization of Lymphatic Vessels and Identification of Lymph Nodes During Sentinel Lymph Node Biopsy in Subjects With Breast Cancer

A Study to Evaluate Patient Preference and Satisfaction of Subcutaneous Administration of the Fixed-Dose Combination of Pertuzumab and Trastuzumab in Participants With HER2-Positive Early Breast Cancer

Safety of GQ1001 in Adult Patients With HER2-Positive Advanced Solid Tumors

Other Conditions in Massachusetts